APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 17 analysts with an average price target of $40.43. This is a potential upside of $15.12 (59.74%) from yesterday's end of day stock price of $25.31.

Apellis Pharmaceuticals's activity chart (see below) currently has 435 price targets and 305 ratings on display. The stock rating distribution of APLS is 46.51% HOLD, 51.16% BUY and 2.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.66% with an average time for these price targets to be met of 201.85 days.

Highest price target for APLS is $60, Lowest price target is $18, average price target is $32.75.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 03-Nov-2025. First documented stock forecast 04-Dec-2017.

Currently out of the existing stock ratings of APLS, 20 are a HOLD (46.51%), 22 are a BUY (51.16%), 1 are a SELL (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$45

$23.41 (108.43%)

$52

1 months 13 days ago
(03-Nov-2025)

20/28 (71.43%)

$23.53 (109.59%)

216

Hold

$19

$-2.59 (-12.00%)

$20

1 months 13 days ago
(03-Nov-2025)

6/12 (50%)

$-2.47 (-11.50%)

51

Buy

$45

$23.41 (108.43%)

$57

1 months 13 days ago
(03-Nov-2025)

3/23 (13.04%)

$23.53 (109.59%)

108

Buy

$45

$23.41 (108.43%)

$50

1 months 13 days ago
(03-Nov-2025)

5/7 (71.43%)

$23.53 (109.59%)

277

Buy

$32

$10.41 (48.22%)

$81

2 months 1 days ago
(15-Oct-2025)

12/13 (92.31%)

$6.77 (26.83%)

94

Show more analysts

Please expand the browser size to see the chart

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 201.85 days on average for the stock forecasts to be realized with a an average price target met ratio 65.66

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at CANTOR FITZGERALD and has 4 price targets and 3 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $119.41

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$3.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?